ChipMOS TECHNOLOGIES (NASDAQ:IMOS) reported quarterly earnings of $0.58 per share. This is a 57.97 percent decrease over earnings of $1.38 per share from the same period last year. The company reported $165.30 million in sales this quarter. This is a 35.73 percent decrease over sales of $257.20 million the same period last year.
How Bad Are Concert Pharmaceuticals’s Earnings? | Return On Capital Employed
Benzinga Pro data, Concert Pharmaceuticals (NASDAQ:CNCE) reported Q3 sales of $543.00 thousand. Earnings fell to a loss of $26.80 million, resulting in a 530.86% decrease from last quarter.
